Report cover image

Nanobodies Market, By Product Type (Monovalent Nanobodies, Bivalent Nanobodies, Bispecific Nanobodies, Biparatopic Nanobodies, Multivalent Nanobodies, Fusion Nanobodies), By Therapeutic Area (Oncology, Infectious Diseases, Inflammatory and Autoimmune Dise

Publisher Coherent Market Insights
Published Mar 21, 2025
Length 175 Pages
SKU # CMI20004576

Description

Nanobodies are engineered antibodies that have a single domain developed by heavy chains with antigen–binding. These antibodies can be engineered and are suitable for various applications for research, therapeutic development, and medical diagnosis due to their size and single-chain nature. Nanobodies have various interesting applications including research on clinical therapeutics. Nanobodies are extensively used in the field of diagnosis and research, and it plays a crucial role and has great potential in noninvasive in vivo imaging. Nanobodies meet requirements to become a generic imaging tracer and offer benefits in molecular imaging, which leads to an increase in the use of nanobodies.

Market Dynamics

Market players are indulged in research and development activities for advancement of nanobodies for therapeutical treatments, which is expected to drive the growth of the global nanobodies market over the forecast period. For instance, according to an article published on Nature Journal on December 21, 2020, researchers at National Institutes of Health isolated a set of nanobodies against SARS-CoV-2. This nanobody is called NIH-CoVnb-112, which binds and blocks the variant form of SARS-Cov-2 spike protein.

Increasing awareness about early diagnosis as well as treatment is expected to drive the growth of the global nanobodies market over the forecast period. For instance, in October 2020, the Government Royapettah Hospital (GRH) organized an awareness program on breast cancer in India. This enabled to increase early detection, diagnosis, and availability of advanced technologies to improve survival rate of patients. This program aimed to create awareness about breast cancer and prevention at an early stage through early detection to avoid further consequences. By using nanobodies, which work as substitutes for naturally occurring antibodies for cancer treatment, they bind to the antigens on the surface of cancer cells, which helps to detect the cancer cells and block their growth. This can help in reducing the prevalence of cancer.

Key features of the study:
  • This report provides an in-depth analysis of global nanobodies market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global nanobodies market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include Merck KGaA, Sanofi (Ablynx), Alphamab Oncology, Novartis AG, Genscript, Taisho Pharmaceutical Holdings Co., Ltd., Sensei Biotherapeutics, Inc., Cusabio Technology LLC., ChromoTek GmbH, Beroni Group, ExeVir Bio BV, Absolute Antibody, Alpalife (Shenzhen kangti Co., Ltd.), DiosCURE Therapeutics SE, Thermo Fisher Scientific Inc., PerkinElmer Inc. (BioLegend, Inc.), and Abnova Corporation
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global nanobodies market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nanobodies market
Detailed Segmentation:
  • Global Nanobodies Market, By Product Type :
  • Mono specific Nanobodies
  • Monovalent Nanobodies
  • Multivalent Nanobodies
  • Bi-paratopic Nanobodies
  • Multi specific Nanobodies
  • Fusion Nanobodies
  • Global Nanobodies Market, By Application:
  • Therapeutic
  • Diagnostic
  • Global Nanobodies Market, By Distribution Channel:
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Global Nanobodies Market, By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
  • Company Profiles
  • Merck KGaA
  • Sanofi (Ablynx)
  • Alphamab Oncology
  • Novartis AG
  • Genscript
  • Taisho Pharmaceutical Holdings Co., Ltd.
  • Sensei Biotherapeutics, Inc.
  • Cusabio Technology LLC.
  • ChromoTek GmbH
  • Beroni Group
  • ExeVir Bio BV
  • Absolute Antibody
  • Alpalife (Shenzhen kangti Co., Ltd.)
  • DiosCURE Therapeutics SE
  • Thermo Fisher Scientific Inc.
  • PerkinElmer Inc. (BioLegend, Inc.)
  • Abnova Corporation

Table of Contents

175 Pages
1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Product Type
Market Snippet, By Therapeutic Area
Market Snippet, By Application
Market Snippet, By End User
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Opportunities
Recent Trends
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis
PORTER’s Analysis
4. Global Nanobodies Market – COVID-19 Impact Analysis
Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand
5. Global Nanobodies Market, By Product Type, 2020– 2032, (US$ Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021–2032
Segment Trends
Monovalent Nanobodies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Mn)
Segment Trends
Bivalent Nanobodies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Mn)
Segment Trends
Bispecific Nanobodies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Mn)
Segment Trends
Biparatopic Nanobodies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Mn)
Segment Trends
Multivalent Nanobodies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Mn)
Segment Trends
Fusion Nanobodies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Mn)
Segment Trends
6. Global Nanobodies Market, By Therapeutic Area, 2020 – 2032, (US$ Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021–2032
Segment Trends
Oncology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Mn)
Segment Trends
Infectious Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Mn)
Segment Trends
Inflammatory and Autoimmune Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Mn)
Segment Trends
Neurological Disorders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Mn)
Segment Trends
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Mn)
Segment Trends
7. Global Nanobodies Market, By Application, 2020 – 2032, (US$ Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021–2032
Segment Trends
Therapeutic
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Mn)
Segment Trends
Diagnostic
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Mn)
Segment Trends
Research
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Mn)
Segment Trends
8. Global Nanobodies Market, By End User, 2020 – 2032, (US$ Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021–2032
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Mn)
Biopharmaceutical Companies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Mn)
Diagnostic Laboratories
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Mn)
Segment Trends
9. Global Nanobodies Market, By Region, 2020 – 2032, (US$ Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021–2032
Segment Trends
North America
Market Size and Forecast,Y-o-Y Growth, By Product Type, 2020–2032, (US$ Mn)
Market Size and Forecast, Y-o-Y Growth, By Therapeutic Area, 2020–2032, (US$ Mn)
Market Size and Forecast, Y-o-Y Growth, By Application, 2020–2032, (US$ Mn)
Market Size and Forecast,Y-o-Y Growth, By End User, 2020–2032, (US$ Mn)
Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2020–2032, (US$ Mn)
U.S.
Canada
Europe
Asia Pacific
Latin America
Middle East
Africa
10. Competitive Landscape
Company Profiles
Merck KGaA
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Sanofi
AlpalifeB Inc
GenScript
Novartis International AG
Taisho Pharmaceutical Holdings Co., Ltd.
Sino Biological, Inc.
GeneMedi
Biocytogen
Abnova Corporation
NanoTag Biotechnologies
Avillion LLP
Capra Science
Numab Therapeutics
CUSABIO TECHNOLOGY LLC
Proteintech Group, Inc.
GT Biopharma, Inc.
Confo Therapeutics
R&D Systems, Inc.
Abcepta Biotech Ltd. Co.
Analysts’ Views
11. Section
References
Research Methodology
About us and Sales Contact
*Browse 44 market data tables and 41 figures on “Global Nanobodies Market” – Global forecast to 2032

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us